Navigation Links
Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits
Date:12/21/2011

e right treatment for the right patient can make all the difference, particularly in cancer patients.  To learn more about our company, products, and potentially life-saving cancer test, visit www.radient-pharma.com.

Forward-Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

For additional information on Radient Pharmaceuticals Corporation and its products visit: www.radient-pharma.com or www.onko-sure.com or e-mail info@radient-pharma.com.  For Investor Relations contact Paul Knopick at: pknopick@eandecommunications.com or 949-707-5365.


'/>"/>
SOURCE Radient Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
2. Radient Pharmaceuticals Corporation Joins OTCQX
3. Merriman Capital Announces Sponsorship of Radient Pharmaceuticals Corporation on OTCQX
4. Radient Pharmaceuticals Announces FY 2011 Third Quarter Results
5. Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
6. Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital
7. Radient Pharmaceuticals Corporation Receives $500,000 in New Capital
8. Radient Pharmaceuticals Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation
9. Radient Pharmaceuticals Submits an Abstract to the American Society of Colon and Rectal Surgeons
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ... Testing Market"  report to their offering. ... ,Major issues pertaining to the UK NAT ... regulatory, demographic, social and technological trends with ...
(Date:5/27/2015)... 2015 Research and ... of the  "2015 Strategies in the Global ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... of the orthopedics market, including forecasts for ... categories. , ,In addition, the report presents ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "2015 Strategies in the ... to their offering.       (Logo: ... designed to help current suppliers and potential ... emerging in the French coagulation testing market ...
Breaking Medicine Technology:Global Orthopedics Market Strategies 2015 2United States Hemostasis Diagnostic Testing Market Strategies 2015 2
... BMR, TORONTO, July 10, 2007 /PRNewswire-FirstCall/ - ... the,development and commercialization of cancer therapies, today,announced ... team in,Basel, Switzerland validates tenascin as an ... treatments for glioblastoma,multiforme (GBM). , The researchers ...
... BioPharma, Inc.,(Nasdaq:AVII) announced today that its partner Cook ... data from a Phase II clinical trial known ... was designed to study,the effect of the Neugene(R) ... placement of one or more bare metal,stents, in ...
Cached Medicine Technology:Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2
(Date:5/27/2015)... May 27, 2015 In support of ... 2015 issue of the Journal of American Geriatrics Society ... abdominal obesity, Bedford Commons OB-GYN P.A . is ... non-nutritive sweetener-flavored beverages. , To examine the relationship ... comprehensive San Antonio Longitudinal Study of Aging (SALSA) tracked ...
(Date:5/27/2015)... May 27, 2015 The Case ... a partnership to provide CMSA's Career and Knowledge ... collaboration seeks to strengthen the case/care management workforce ... CKP program. The mutually beneficial agreement provides Medix, ... skills of talent in the healthcare, scientific and ...
(Date:5/27/2015)... SAN DIEGO, May 27, 2015 ... the first healthcare provider along the Gulf Coast ... management (CCM). In partnership with MD Revolution, a ... a new program that enables healthcare providers to ... reimbursements. This new, user-friendly program is designed to ...
(Date:5/27/2015)... CompanionDx announced that its ... analysis in personalized cancer therapy: Non-small cell lung cancer ... of Clinical Oncology (ASCO) as part of their annual ... The molecular and clinical data used for the study ... The study reports improved patient outcomes from a preliminary ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
Breaking Medicine News(10 mins):Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Donate Your Break and Save Lives at the River North Blood Drive 2
... 10 Warner Chilcott plc (Nasdaq: WCRX ) ... lawsuits against Lupin Limited and its wholly owned subsidiary Lupin ... District of Delaware for infringement of Warner Chilcott,s U.S. Patent ... which cover oral contraceptives LOESTRIN 24 FE and FEMCON FE, ...
... to treat major depression. Many antidepressant medications are available, but no ... right for an individual. As a result, for more than half ... can take months to figure out what does. Now, based ... clinicians may be able to accurately predict within a week whether ...
... The University of Miami School of Nursing and Health Studies ... Foundation in the amount of $30,000 to support six students ... program. "Family nurse practitioners have a promising future" said Nilda ... Studies. "The Dr. John T. Macdonald Foundation grant will help ...
... threat, just like swine flu , THURSDAY, Sept 10 (HealthDay News) ... flu poses a real threat this fall, too. , And the ... Then follow it up with an H1N1 swine flu vaccine when ... Thursday from U.S. health officials, who noted that seasonal flu puts ...
... , , , ... and breadth of the H1N1 virus - the upcoming revisit of ... dangerously low preparedness plans within the private sector. "There,s no question ... Kineo Group. "Businesses are navigating a daunting market and obstacles not ...
... PEMBROKE, Bermuda, Sept. 10 Allied ... announced today that Allied,World,s Chief Operating Officer, David Bell, ... Symposium at the Cityplace Conference Center in,Dallas, Texas on ... Entrepreneurial Insurance Symposium is organized by MarketScout, and,the theme ...
Cached Medicine News:Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 2Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 3Health News:Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents 4Health News:UCLA researchers develop biomarker for rapid relief of major depression 2Health News:UCLA researchers develop biomarker for rapid relief of major depression 3Health News:UM receives grant to support graduate students in the family nurse practitioner program 2Health News:Get Your Vaccine for Seasonal Flu, Experts Urge 2Health News:Get Your Vaccine for Seasonal Flu, Experts Urge 3Health News:H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 2Health News:Allied World's David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 2Health News:Allied World's David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 3
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... lets you sleep on your ... the morning awake with your ... to take on the day. ... and protection, this preservative-free lubricant ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: